ADAP
Adaptimmune Therapeutics
ADAP
ADAP
80 hedge funds and large institutions have $397M invested in Adaptimmune Therapeutics in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 27 closing their positions.
Holders
80
Holders Change
-13
Holders Change %
-13.98%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
14
Increased
27
Reduced
24
Closed
27
Calls
$2.25M
Puts
$136K
Net Calls
+$2.12M
Net Calls Change
-$5.63M